The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.
Open accessAbstract
BACKGROUND: Brief episodes of ischemia render the heart more resistant to subsequent ischemia; this phenomenon has been called ischemic preconditioning. In some animal species, myocardial preconditioning appears to be due to activation of ATP-sensitive K+ (KATP) channels. The role played by KATP channels in preconditioning in humans remains unknown. The aim of this study was to establish whether glibenclamide, a selective KATP channel blocker, abolishes the ischemic preconditioning observed in humans during coronary angioplasty following repeated balloon inflations. METHODS AND RESULTS: Twenty consecutive patients undergoing one-vessel coronary angioplasty were randomized to receive 10 mg oral glibenclamide or placebo. Sixty minutes after glibenclamide or placebo administration, patients were given an infusion of 10% dextrose (8 mL/min) to correct glucose plasma levels or, respectively, an infusion of saline at the same infusion rate. Thirty minutes after the beginning of the infusion, both patient groups underwent coronary angioplasty. The mean values (+/- 1 SD) of ST-segment shifts on the surface 12-lead ECG and the intracoronary ECG were measured at the end of the first and second balloon inflations, both 2 minutes long. In glibenclamide-treated patients, the mean ST-segment shift during the second balloon inflation was similar to that observed during the first inflation (23 +/- 13 versus 20 +/- 8 mm, P = NS), and the severity of cardiac pain was greater (55 +/- 21 versus 43 +/- 23 mm on a scale of 0 to 100, P < .05). Conversely, in placebo-treated patients the mean ST-segment shift during the second inflation was less than that during the first inflation (9 +/- 5 versus 23 +/- 13 mm, P < .001), as was the severity of cardiac pain (15 +/- 15 versus 42 +/- 19 mm, P < .01). Blood glucose levels were significantly reduced 60 minutes after glibenclamide compared with those at baseline (53 +/- 9 versus 102 +/- 10 mg/100 mL, P < .001) in the glibenclamide group; however, before coronary angioplasty, blood glucose levels increased to 95 +/- 19 mg/100 mL, a value similar to that found in placebo group (96 +/- 11 mg/100 mL, P = NS). CONCLUSIONS: In humans, ischemic preconditioning during brief repeated coronary occlusions is completely abolished by pretreatment with glibenclamide, thus suggesting that it is mainly mediated by KATP channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
Huskisson, E. C. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90884-8 · Cited by 4,522
ATP-regulated K+ channels in cardiac muscle
Noma, A. (1983) · Nature · doi:10.1038/305147a0 · Cited by 2,328
Liu, G. S., Thornton, J., Van Winkle, D. M., Stanley, A. W., Olsson, R. A., & Downey, J. M. (1991) · Circulation · doi:10.1161/01.cir.84.1.350 · Cited by 1,351
Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
Gross, G. J., & Auchampach, J. A. (1992) · Circulation Research · doi:10.1161/01.res.70.2.223 · Cited by 949
Murry, C. E., Richard, V. J., Reimer, K. A., & Jennings, R. B. (1990) · Circulation Research · doi:10.1161/01.res.66.4.913 · Cited by 770
Deutsch, E., Berger, M., Kussmaul, W. G., Hirshfeld, J. W., Herrmann, H. C., & Laskey, W. K. (1990) · Circulation · doi:10.1161/01.cir.82.6.2044 · Cited by 594
Hypoxic Dilation of Coronary Arteries Is Mediated by ATP-Sensitive Potassium Channels
Daut, J., Maier-Rudolph, W., von Beckerath, N., Mehrke, G., Günther, K., & Goedel-Meinen, L. (1990) · Science · doi:10.1126/science.2107575 · Cited by 593
Ischemic preconditioning reduces infarct size in swine myocardium.
Schott, R. J., Rohmann, S., Braun, E. R., & Schaper, W. (1990) · Circulation Research · doi:10.1161/01.res.66.4.1133 · Cited by 559
ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.
Cole, W. C., McPherson, C. D., & Sontag, D. (1991) · Circulation Research · doi:10.1161/01.res.69.3.571 · Cited by 469
Cited by
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Myocardial No-Reflow in Humans
Niccoli, G., Burzotta, F., Galiuto, L., & Crea, F. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.054 · Cited by 853
Self-citationHeusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Investigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology
Grover, G. J., & Garlid, K. D. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1111 · Cited by 396
Schultz, J. E. J., Hsu, A. K., & Gross, G. J. (1996) · Circulation Research · doi:10.1161/01.res.78.6.1100 · Cited by 366
ATP-sensitive K+channels in pancreatic, cardiac, and vascular smooth muscle cells
Yokoshiki, H., Sunagawa, M., Seki, T., & Sperelakis, N. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c25 · Cited by 350
Myocardial KATPChannels in Preconditioning
O’Rourke, B. (2000) · Circulation Research · doi:10.1161/01.res.87.10.845 · Cited by 347
Garratt, K. N., Brady, P. A., Hassinger, N. L., Grill, D. E., Terzic, A., & Holmes, D. R. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00557-9 · Cited by 332
Mitochondrial Channels: Ion Fluxes and More
Szabo, I., & Zoratti, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00021.2013 · Cited by 321
Cleveland, J. C., Meldrum, D. R., Cain, B. S., Banerjee, A., & Harken, A. H. (1997) · Circulation · doi:10.1161/01.cir.96.1.29 · Cited by 294
Speechly-Dick, M. E., Grover, G. J., & Yellon, D. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.1030 · Cited by 289
Sulphonylurea action revisited: the post-cloning era
Gribble, F. M., & Reimann, F. (2003) · Diabetologia · doi:10.1007/s00125-003-1143-3 · Cited by 284
Ischemic Preconditioning in Humans: Models, Mediators, and Clinical Relevance
Tomai, F., Crea, F., Chiariello, L., & Gioffrè, P. A. (1999) · Circulation · doi:10.1161/01.cir.100.5.559 · Cited by 274
Self-citationIschaemic preconditioning: present position and future directions
Yellon, D. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00214-9 · Cited by 257
The UGDP Controversy: thirty-four years of contentious ambiguity laid to rest
Schwartz, T. B., & Meinert, C. L. (2004) · Perspectives in Biology and Medicine · doi:10.1353/pbm.2004.0071 · Cited by 85
Nitrite as a mediator of ischemic preconditioning and cytoprotection
Murillo, D., Kamga, C., Mo, L., & Shiva, S. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.01.003 · Cited by 57
Transgenic overexpression of cardiac A1adenosine receptors mimics ischemic preconditioning
Morrison, R. R., Jones, R., Byford, A. M., Stell, A. R., Peart, J., Headrick, J. P., & Matherne, G. P. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1071 · Cited by 44
Tegegne, B. A., Yihunie, W., Aschale, Y., Belew, H., & Getachew, M. (2024) · Global Advances in Integrative Medicine and Health · doi:10.1177/27536130231225464 · Cited by 1
Metadata
- Authors
- Tomai, F., Crea, F., Gaspardone, A., Versaci, F., De Paulis, R., Penta de Peppo, A., Chiariello, L., & Gioffrè, P. A.
- Venue
- Circulation
- Published
- 1994-08
- Volume
- 90
- Issue
- 2
- Pages
- 700-705
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2002991383
- Cited by
- 475
- References
- 34
- FWCI
- 27.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.